VAERS reports by lot

Merck HPV lot K011325: VAERS reports

29 VAERS reports list lot K011325 as a Merck HPV vaccine, received between 2015-06-29 and 2017-03-24. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
7%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)729%
Neurological625%
Cardiac / Cardiovascular312%
Gastrointestinal312%
Musculoskeletal28%
Dermatological (non-injection-site)28%
Allergic / Anaphylactic14%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Texas3
Tennessee2
Maine1
Maryland1
Ohio1
Oregon1
Oklahoma1
Florida1
New York1
Kansas1
New Jersey1
Pennsylvania1

Reports by month received

MonthReportsBar
2015-061
2015-074
2015-084
2015-091
2015-101
2015-111
2015-122
2016-014
2016-025
2016-031
2016-051
2016-081
2016-091
2016-111
2017-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Merck HPV lots (A–Z): K009482 · K010215 · K010574 · K011492 · K011562 · K014191

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.